These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 10626050

  • 21. More thoughts about antimalarials: should one prescribe chloroquine?
    Esdaile JM.
    J Rheumatol; 1999 Sep; 26(9):1868. PubMed ID: 10493663
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
    Bahloul E, Jallouli M, Garbaa S, Marzouk S, Masmoudi A, Turki H, Bahloul Z.
    Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
    [Abstract] [Full Text] [Related]

  • 25. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
    Unübol M, Ayhan M, Guney E.
    J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846
    [No Abstract] [Full Text] [Related]

  • 26. Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data.
    Chambers CD, Tutuncu ZN, Johnson D, Jones KL.
    Arthritis Res Ther; 2006 Jan; 8(4):215. PubMed ID: 16774693
    [Abstract] [Full Text] [Related]

  • 27. [Combined drug therapy in recent-onset rheumatoid arthritis. Evaluation after 1 year of treatment].
    Biasi D, Caramaschi P, Carletto A, Pacor ML, Zeminian S, Bambara LM.
    Recenti Prog Med; 1998 Jan; 89(1):14-7. PubMed ID: 9549387
    [Abstract] [Full Text] [Related]

  • 28. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
    Houpt JB.
    J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy.
    Bermas BL.
    Curr Opin Rheumatol; 2014 May; 26(3):334-40. PubMed ID: 24663106
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Rheumatoid arthritis: how to use drugs during pregnancy and lactation?].
    Meriño-Ibarra E, Delgado Beltrán C.
    Reumatol Clin; 2011 May; 7(4):262-6. PubMed ID: 21794829
    [Abstract] [Full Text] [Related]

  • 34. Synthetic antimalarial drugs and the triggering of psoriasis - do we need disease-specific guidelines for the management of patients with psoriasis at risk of malaria?
    Gravani A, Gaitanis G, Zioga A, Bassukas ID.
    Int J Dermatol; 2014 Mar; 53(3):327-30. PubMed ID: 24320605
    [Abstract] [Full Text] [Related]

  • 35. Optimisation of antirheumatic drug treatment in pregnancy.
    Ostesen M.
    Clin Pharmacokinet; 1994 Dec; 27(6):486-503. PubMed ID: 7882637
    [Abstract] [Full Text] [Related]

  • 36. Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy.
    Shrim A, Koren G.
    Can Fam Physician; 2005 May; 51(5):667-8. PubMed ID: 15934268
    [Abstract] [Full Text] [Related]

  • 37. Hydroxychloroquine-induced hyperpigmentation: a case report.
    Melikoglu MA, Melikoglu M, Gurbuz U, Budak BS, Kacar C.
    J Clin Pharm Ther; 2008 Dec; 33(6):699-701. PubMed ID: 19138249
    [Abstract] [Full Text] [Related]

  • 38. Adverse events in methotrexate-treated rheumatoid arthritis patients.
    Sandoval DM, Alarcón GS, Morgan SL.
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
    [Abstract] [Full Text] [Related]

  • 39. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C, Fortin PR, Li Y, Panaritis T, Gans M, Esdaile JM.
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [Abstract] [Full Text] [Related]

  • 40. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
    Wassenberg S, Rau R.
    J Rheumatol; 2003 Aug; 30(8):1891; author reply 1891-2. PubMed ID: 12913889
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.